Table 3.
Pretreatment | Post treatment | 1-month follow-up |
P
value |
||||
CBT | WL | CBT | WL | CBT | WL | ||
MDDc,d | 30 (7) | 30 (7) | 21 (11) | 24 (9) | 20 (12) | 24 (10) | .49 |
No MDD | 27 (7) | 26 (7) | 18 (9) | 21 (8) | 19 (10) | 20 (8) | |
Anxiety disorderd | 32 (7) | 31 (8) | 23 (11) | 25 (9) | 22 (11) | 25 (10) | .71 |
No anxiety disorder | 27 (7) | 26 (6) | 19 (10) | 21 (8) | 19 (11) | 21 (8) | |
Elevated diabetes-specific emotional distress (PAID ≥40)e | 31 (7) | 31 (8) | 22 (11) | 24 (9) | 21 (12) | 24 (9) | .92 |
No elevated diabetes-specific emotional distress (PAID >40)e | 26 (7) | 26 (6) | 18 (10) | 22 (9) | 18 (10) | 21 (9) |
a Center for Epidemiologic Studies Depression scale.
b Data are given as mean (SD). Statistical tests relied on generalized estimating equation analyses. P values indicate level of significance of effect modification. All analyses are adjusted for baseline CES-D scores, baseline between-group differences on sociodemographic variables, and differences in time between pretreatment and posttreatment. Data are uncorrected.
c Major depressive disorder.
d Diagnosed using the computerized version of the World Health Organization Composite International Diagnostic Interview (WHO CIDI-auto).
e Problem Areas In Diabetes scale.